SGLT2 inhibitors and amputation risk: Real-world data from a diabetes foot wound clinic

J Clin Transl Endocrinol. 2018 Jul 17:13:46-47. doi: 10.1016/j.jcte.2018.07.002. eCollection 2018 Sep.

Authors

Jasper Sung¹, Suja Padmanabhan^{1

2}, Seema Gurung¹, Sally Inglis¹, Mauro Vicaretti³, Lindy Begg⁴, N Wah Cheung^{1

2}, Christian M Girgis^{1

2

5}

Affiliations

¹ Department of Diabetes and Endocrinology, Westmead Hospital, Sydney, Australia.
² University of Sydney, Sydney, Australia.
³ Department of Vascular Surgery, Westmead Hospital, Sydney, Australia.
⁴ Foot Wound Clinic, Westmead Hospital, Sydney, Australia.
⁵ Department of Diabetes and Endocrinology, Royal North Shore Hospital, Sydney, Australia.

No abstract available